Thyroid C-mobile Tumors: In rodent studies, semaglutide has been demonstrated to induce thyroid C-cell tumors. It is unidentified whether this chance relates to humans, but semaglutide is contraindicated in individuals with a personal or family members record of medullary thyroid carcinoma (MTC) or sufferers with Several Endocrine Neoplasia syndrom